The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: A nested case-control study

Breast Cancer Research

Volumn 13, Issue 5, 2011, Pages

  Tworoger, Shelley S ^a,b   Rosner, Bernard A ^a,b   Willett, Walter C ^a,b   Hankinson, Susan E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; C PEPTIDE; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; ESTRONE SULFATE; GROWTH HORMONE; PRASTERONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; ESTROGEN;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RISK ASSESSMENT; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; BREAST NEOPLASMS; C-PEPTIDE; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RISK FACTORS; TESTOSTERONE;

EID: 80054746537     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3040     Document Type: Article

References (40)

1. Key T, Appleby P, Barnes I, Reeves G, . Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002, 94:606-616. Endogenous Hormones and Breast Cancer Collaborative Group.
2. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004, 96:1856-1865. 10.1093/jnci/djh336, 15601642.
3. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005, 12:1071-1082. 10.1677/erc.1.01038, 16322344.
4. Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I, Kim MY, Rinaldi S, Kaaks R, Toniolo P. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 2004, 90:153-159. 10.1038/sj.bjc.6601517, 2395327, 14710223.
5. Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 2007, 25:1482-1488. 10.1200/JCO.2006.07.6356, 17372279.
6. Shi R, Yu H, McLarty J, Glass J. IGF-I and breast cancer: a meta-analysis. Int J Cancer 2004, 111:418-423. 10.1002/ijc.20233, 15221971.
7. Yu H, Shu XO, Li BD, Dai Q, Gao YT, Jin F, Zheng W. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003, 12:1067-1073.
8. Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010, 11:530-542. 3113287, 20472501.
9. Trichopoulos D, Bamia C, Lagiou P, Trichopoulou A. Are mammotropic hormones mainly permissive for the development of breast cancer?. Int J Cancer 2006, 118:2863-2865. 10.1002/ijc.21718, 16381008.
10. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C, Speizer FE. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995, 87:1297-1302. 10.1093/jnci/87.17.1297, 7658481.
11. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998, 351:1393-1396. 10.1016/S0140-6736(97)10384-1, 9593409.
12. Franz C, Watson D, Longcope C. Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis. Steroids 1979, 34:563-573. 10.1016/S0039-128X(79)80017-3, 229590.
13. Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 1982, 16:801-810. 10.1016/0022-4731(82)90038-3, 7202083.
14. Rosner B. Percentage points for a generalized ESD many-outlier procedure. Technometrics 1983, 25:165-172.
15. Jozan S, Moure C, Gillois M, Bayard F. Effects of estrone on cell proliferation of a human breast cancer (MCF-7) in long term tissue culture. J Steroid Biochem 1979, 10:341-342. 10.1016/0022-4731(79)90263-2, 459497.
16. Enriori PJ, Vázquez SM, Chiauzzi V, Pérez C, Fischer CR, Gori JR, Etkin AE, Charreau E, Calandra RS, Lüthy IA. Breast cyst fluids increase the proliferation of breast cell lines in correlation with their hormone and growth factor concentration. Clin Endocrinol (Oxf) 2006, 64:20-28.
17. Suzuki T, Ide K, Ishida M. Response of MCF-7 human breast cancer cells to some binary mixtures of oestrogenic compounds in-vitro. J Pharm Pharmacol 2001, 53:1549-1554.
18. Lippert C, Seeger H, Mueck AO. The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci 2003, 72:877-883. 10.1016/S0024-3205(02)02305-6, 12493568.
19. Santner SJ, Ohlsson-Wilhelm B, Santen RJ. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures. Int J Cancer 1993, 54:119-124. 10.1002/ijc.2910540119, 8478138.
20. Billich A, Nussbaumer P, Lehr P. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. J Steroid Biochem Mol Biol 2000, 73:225-235. 10.1016/S0960-0760(00)00077-7, 11070351.
21. Reddel RR, Sutherland RL. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res 1987, 47:5323-5329.
22. Andersen HR, Andersson AM, Arnold SF, Autrup H, Barfoed M, Beresford NA, Bjerregaard P, Christiansen LB, Gissel B, Hummel R, Jørgensen EB, Korsgaard B, Le Guevel R, Leffers H, McLachlan J, Møller A, Nielsen JB, Olea N, Oles-Karasko A, Pakdel F, Pedersen KL, Perez P, Skakkeboek NE, Sonnenschein C, Soto AM, Sumpter JP, Thorpe SM, Grandjean P. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect 1999, 107(Suppl 1):89-108. 10.1289/ehp.99107s189, 1566352, 10229711.
23. Andò S, De Amicis F, Rago V, Carpino A, Maggiolini M, Panno ML, Lanzino M. Breast cancer: from estrogen to androgen receptor. Mol Cell Endocrinol 2002, 193:121-128. 10.1016/S0303-7207(02)00105-3, 12161011.
24. Gayosso V, Montano LF, López-Marure R. DHEA-induced antiproliferative effect in MCF-7 cells is androgen- and estrogen receptor-independent. Cancer J 2006, 12:160-165.
25. Klevjer-Anderson P, Buehring GC. Effect of hormones on growth rates of malignant and nonmalignant human mammary epithelia in cell culture. Vitro 1980, 16:491-501.
26. Schmitt M, Klinga K, Schnarr B, Morfin R, Mayer D. Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol. Mol Cell Endocrinol 2001, 173:1-13. 10.1016/S0303-7207(00)00442-1, 11223173.
27. Macedo LF, Guo Z, Tilghman SL, Sabnis GJ, Qiu Y, Brodie A. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole. Cancer Res 2006, 66:7775-7782. 10.1158/0008-5472.CAN-05-3984, 16885381.
28. Santner SJ, Chen S, Zhou D, Korsunsky Z, Martel J, Santen RJ. Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J Steroid Biochem Mol Biol 1993, 44:611-616. 10.1016/0960-0760(93)90267-Z, 8476772.
29. Kiss R, de Launoit Y, Wouters W, Deslypere JP, Lescrainier JP, Paridaens R, Vokaer A, Decoster R, Pasteels JL. Inhibitory action of androstenedione on the proliferation and cell cycle kinetics of aromatase-free MXT and MCF-7 mammary tumour cell lines. Eur J Cancer Clin Oncol 1989, 25:837-843. 10.1016/0277-5379(89)90129-6, 2737220.
30. Biswas R, Vonderhaar BK. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res 1987, 47:3509-3514.
31. Döll F, Pfeilschifter J, Huwiler A. Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration. Endocr Relat Cancer 2007, 14:325-335. 10.1677/ERC-06-0050, 17639048.
32. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000, 21:427-433. 10.1093/carcin/21.3.427, 10688862.
33. Tworoger SS, Hankinson SE. Prolactin and breast cancer risk. Cancer Lett 2006, 243:160-169. 10.1016/j.canlet.2006.01.032, 16530327.
34. Liao DJ, Dickson RB. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 2002, 80:175-189. 10.1016/S0960-0760(01)00185-6, 11897502.
35. Liao DZ, Pantazis CG, Hou X, Li SA. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors. Carcinogenesis 1998, 19:2173-2180. 10.1093/carcin/19.12.2173, 9886575.
36. Xie B, Tsao SW, Wong YC. Induction of high incidence of mammary tumour in female Noble rats with a combination of 17β-oestradiol and testosterone. Carcinogenesis 1999, 20:1069-1078. 10.1093/carcin/20.6.1069, 10357790.
37. Gutzman JH, Miller KK, Schuler LA. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor α and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells. J Steroid Biochem Mol Biol 2004, 88:69-77. 10.1016/j.jsbmb.2003.10.008, 15026085.
38. Stewart AJ, Johnson MD, May FE, Westley BR. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990, 265:21172-21178.
39. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995, 4:649-654.
40. Santen RJ, Boyd NF, Chlebowski RT, Cummings S, Cuzick J, Dowsett M, Easton D, Forbes JF, Key T, Hankinson SE, Howell A, Ingle J, . Breast Cancer Prevention Collaborative Group Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer 2007, 14:169-187. 10.1677/ERC-06-0045, 17639036, Breast Cancer Prevention Collaborative Group.